Isabel de Castro-Orós

Author

Hospital Universitario Miguel Servet ORCID

Also Known As

I Castro, I. Castro, I. De Castro, I. De Castro-Orós, I. de Castro, I. de Castro-Oros, I. de Castro-Orós, Isabel De Castro-Orós, Isabel De Castro‐Orós, Isabel De Castro–Orós

Publications

651

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Miguel Servet Universidad de Zaragoza Instituto de Investigación Sanitaria Aragón Instituto de Salud Carlos III Centro de Investigación Biomédica en Red

About

Isabel de Castro-Orós is an author at Hospital Universitario Miguel Servet specializing in medicine, genetics, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	299
2	Public Health	2	2	44
3	Biochemistry	2	2	28
4	Engineering	1	1	37
5	Health Sciences	1	1	37

Isabel de Castro-Orós

Publications

536

Citations

H-Index

Page 1

	Year	Citations
The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes Ana Cenarro, Aitor Etxebarria, Isabel de Castro-Orós, The Journal of Clinical Endocrinology & Metabolism	2016	96
Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia María Solanas-Barca, Isabel de Castro-Orós, Rocío Mateo‐Gállego, Atherosclerosis Metabolic SyndromeMixed HyperlipidemiaGenetic DisorderGeneticsPathology	2012	74
Promoter variant −204A > C of the cholesterol 7α-hydroxylase gene: Association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells Isabel de Castro-Orós, Sandra Pampín, Montserrat Cofán, Clinical Nutrition Transcriptional RegulationOxysterolGeneticsPlant SterolsPromoter Variant −204A	2010	55
Common Genetic Variants Contribute to Primary Hypertriglyceridemia Without Differences Between Familial Combined Hyperlipidemia and Isolated Hypertriglyceridemia Isabel de Castro-Orós, Ana Cenarro, María Teresa Tejedor, Circulation Cardiovascular Genetics	2014	46
Functional analysis of LDLR promoter and 5′ UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia Isabel de Castro-Orós, Sandra Pampín, Alfonso Bolado‐Carrancio, Human Mutation EngineeringGeneticsGenetic EpidemiologyPathologyMolecular Biology	2011	37
Energy-restricted, high-protein diets more effectively impact cardiometabolic profile in overweight and obese women than lower-protein diets Rocío Mateo‐Gállego, Victoria Marco-Benedí, Sofía Pérez‐Calahorra, Clinical Nutrition ObesityMetabolic SyndromeNutritionHealth SciencesCardiovascular Disease	2016	37
APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis Montse Guardiola, Montserrat Cofán, Isabel de Castro-Orós, Atherosclerosis Metabolic SyndromeVascular DiseaseCardiovascular DiseaseGenetic EpidemiologyHyperlipidemic Patients	2015	33
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine Isabel de Castro-Orós, Rosa Solà, Rosa M. Valls, PLoS ONE	2016	26
Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain Itziar Lamíquiz-Moneo, Cristian Blanco-Torrecilla, Ana M. Bea, Lipids in Health and Disease	2016	24
LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population Pilar Irún, Jorge J. Cebolla, Laura López de Frutos, Clinical Chemistry and Laboratory Medicine (CCLM)	2020	24

Page 1